S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
Log in

Orthofix Medical Stock Price, Forecast & Analysis (NASDAQ:OFIX)

$44.83
-0.15 (-0.33 %)
(As of 11/19/2019 04:00 PM ET)
Today's Range
$44.80
Now: $44.83
$45.68
50-Day Range
$41.03
MA: $48.36
$53.53
52-Week Range
$39.75
Now: $44.83
$74.44
Volume110,500 shs
Average Volume130,837 shs
Market Capitalization$854.24 million
P/E Ratio22.87
Dividend YieldN/A
Beta0.38
Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.04 million
Cash Flow$3.06 per share
Book Value$18.05 per share

Profitability

Net Income$13.81 million

Miscellaneous

Employees954
Market Cap$854.24 million
Next Earnings Date2/24/2020 (Estimated)
OptionableOptionable

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.


Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) issued its earnings results on Monday, October, 28th. The medical device company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.51 by $0.10. The medical device company earned $113.50 million during the quarter, compared to the consensus estimate of $117.83 million. Orthofix Medical had a positive return on equity of 9.16% and a negative net margin of 6.81%. The company's quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.44 EPS. View Orthofix Medical's Earnings History.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Orthofix Medical.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY19 earnings guidance on Monday, October, 28th. The company provided earnings per share (EPS) guidance of $1.55-1.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.78. The company issued revenue guidance of $460-463, compared to the consensus revenue estimate of $473.93 million.

What price target have analysts set for OFIX?

2 analysts have issued 1-year price objectives for Orthofix Medical's shares. Their forecasts range from $48.00 to $48.00. On average, they anticipate Orthofix Medical's share price to reach $48.00 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

What is the consensus analysts' recommendation for Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

Media headlines about OFIX stock have been trending very negative on Tuesday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthofix Medical earned a news sentiment score of -3.4 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Orthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a decrease in short interest in the month of October. As of October 31st, there was short interest totalling 378,900 shares, a decrease of 21.1% from the September 30th total of 480,100 shares. Based on an average daily volume of 124,800 shares, the days-to-cover ratio is currently 3.0 days. Currently, 2.1% of the shares of the company are short sold. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX), Allergan (AGN), Edwards Lifesciences (EW), Zoetis (ZTS) and Biogen (BIIB).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the folowing people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Paradice Investment Management LLC (4.27%), Oakview Capital Management L.P. (2.09%), Dalton Greiner Hartman Maher & Co. (1.76%), Tygh Capital Management Inc. (0.74%), Alberta Investment Management Corp (0.46%) and Gamco Investors INC. ET AL (0.44%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

Which institutional investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Tygh Capital Management Inc., Oakview Capital Management L.P., First Trust Advisors LP, Systematic Financial Management LP and Gamco Investors INC. ET AL. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason and Davide Bianchi. View Insider Buying and Selling for Orthofix Medical.

Which institutional investors are buying Orthofix Medical stock?

OFIX stock was bought by a variety of institutional investors in the last quarter, including Paradice Investment Management LLC, Assenagon Asset Management S.A., SG Americas Securities LLC, Dalton Greiner Hartman Maher & Co., Rice Hall James & Associates LLC, Mackay Shields LLC, Alberta Investment Management Corp and Synovus Financial Corp. View Insider Buying and Selling for Orthofix Medical.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $44.83.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $854.24 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is http://www.orthofix.com/.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]


MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  340 (Vote Outperform)
Underperform Votes:  392 (Vote Underperform)
Total Votes:  732
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel